Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Timothée Bruel and Olivier Schwartz.
Connection Strength

4.279
  1. Markers of the HIV-1 reservoir: facts and controversies. Curr Opin HIV AIDS. 2018 09; 13(5):383-388.
    View in: PubMed
    Score: 0.784
  2. Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies. J Virol. 2017 04 15; 91(8).
    View in: PubMed
    Score: 0.710
  3. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature. 2021 08; 596(7871):276-280.
    View in: PubMed
    Score: 0.239
  4. Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies. Cell Rep Med. 2021 05 18; 2(5):100275.
    View in: PubMed
    Score: 0.235
  5. Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies. Nat Med. 2021 05; 27(5):917-924.
    View in: PubMed
    Score: 0.234
  6. Syncytia formation by SARS-CoV-2-infected cells. EMBO J. 2021 Feb 01; 40(3):e107405.
    View in: PubMed
    Score: 0.232
  7. Syncytia formation by SARS-CoV-2-infected cells. EMBO J. 2020 12 01; 39(23):e106267.
    View in: PubMed
    Score: 0.228
  8. HIV-1 cell-to-cell transmission and broadly neutralizing antibodies. Retrovirology. 2018 07 28; 15(1):51.
    View in: PubMed
    Score: 0.195
  9. HIV Fusion in Dendritic Cells Occurs Mainly at the Surface and Is Limited by Low CD4 Levels. J Virol. 2017 11 01; 91(21).
    View in: PubMed
    Score: 0.184
  10. Zika virus induces massive cytoplasmic vacuolization and paraptosis-like death in infected cells. EMBO J. 2017 06 14; 36(12):1653-1668.
    View in: PubMed
    Score: 0.179
  11. Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection. J Infect Dis. 2021 11 16; 224(9):1489-1499.
    View in: PubMed
    Score: 0.061
  12. Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2. J Infect Dis. 2021 09 17; 224(6):983-988.
    View in: PubMed
    Score: 0.061
  13. Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques. Nat Commun. 2021 09 01; 12(1):5215.
    View in: PubMed
    Score: 0.060
  14. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection. EBioMedicine. 2021 Sep; 71:103561.
    View in: PubMed
    Score: 0.060
  15. Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection. Sci Adv. 2021 08; 7(34).
    View in: PubMed
    Score: 0.060
  16. Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual. Open Forum Infect Dis. 2021 Aug; 8(8):ofab369.
    View in: PubMed
    Score: 0.060
  17. SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance. Nat Commun. 2021 07 16; 12(1):4354.
    View in: PubMed
    Score: 0.060
  18. Characteristics Associated with Olfactory and Taste Disorders in COVID-19. Neuroepidemiology. 2021; 55(5):381-386.
    View in: PubMed
    Score: 0.060
  19. Author Correction: Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers. Nat Commun. 2021 May 10; 12(1):2824.
    View in: PubMed
    Score: 0.059
  20. SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020. Euro Surveill. 2021 04; 26(15).
    View in: PubMed
    Score: 0.059
  21. Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers. Nat Commun. 2021 02 08; 12(1):844.
    View in: PubMed
    Score: 0.058
  22. IgA dominates the early neutralizing antibody response to SARS-CoV-2. Sci Transl Med. 2021 01 20; 13(577).
    View in: PubMed
    Score: 0.057
  23. A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations. Sci Transl Med. 2020 09 02; 12(559).
    View in: PubMed
    Score: 0.056
  24. Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France. EBioMedicine. 2020 Sep; 59:102915.
    View in: PubMed
    Score: 0.056
  25. Accelerated thymopoiesis and improved T-cell responses in HLA-A2/-DR2 transgenic BRGS-based human immune system mice. Eur J Immunol. 2019 06; 49(6):954-965.
    View in: PubMed
    Score: 0.051
  26. A human immune system mouse model with robust lymph node development. Nat Methods. 2018 08; 15(8):623-630.
    View in: PubMed
    Score: 0.049
  27. Corrigendum: CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses. Nature. 2017 06 28; 546(7660):686.
    View in: PubMed
    Score: 0.045
  28. CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses. Nature. 2017 03 23; 543(7646):564-567.
    View in: PubMed
    Score: 0.044
  29. Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents. J Virol. 2017 03 15; 91(6).
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.